References
- Lesavre P., Bach J.F. Les immunostimulants?. Immunologie 1980; 30: 908
- Chihara G., Maeda Y.Y., Hamuro Y. Current status and perspectives of immunomodulators of microbial origin. Int. J. Tiss. Reac? IV 1982; 3: 207
- Spreafico F. Problems and challenges in the use of immunomodulating agents. Int. Archs. Allergy Appl. Immun 1985; 76: 108
- Drews J. The experimental and clinical use of immune modulating drugs in the prophylaxis and treatment of infections. Infection 1985; 13: 241
- Johnson A.G. Microbial adjuvants and immune responsiveness. Immunomodulation by bacteria and their products, M. Friedman, T.W. Klein, A. Szentivangi. Plenum Publishing Corp., New York 1981; 1
- Friedman M., Klein T.W., Butler R.C. Bacterial antigens as immunomodulators. Immunomodulation. New frontiers and advances, M. Hugh-Fudenberg, M.D. Whiten. Plenum Publishing Corp., New York 1982; 202
- Bosch A., Lucena F., Pares R., Jofre J. Compensation of cyclophosphamide immunosuppression by a bacterial immunostimulant (Broncho-Vaxom) in mice. J. Immunopharmacol 1984; 6: 323
- Bosch A., Lucena F., Pares R., Jofre J. Bacterial immunostimulant (Broncho-Vaxom) versus levamisole on the humoral immune response in mice. J. Immunopharmacol 1983; 5: 107
- Mancini G., CarbonaraHeremans A.O. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochem 1965; 2: 235
- Lowry O.H., Rosebrough N.J., Farr A.L.Z., Randal R.J. Protein measurement by the Folin phenol reagent. J. Biol. Chem 1951; 193: 266
- Cunningham A.J. A method of increased sensitivity for detecting single antibody-forming cells. Nature 1965; 207: 1106
- Nugent K.M., Cox C.D., Pesanti E.L. Pseudomonas aeruginosa clearance in mice. Comparison of tissue, strain and corticosteroid effects. Infect. Immun 1984; 43: 901
- Bienenstock J., Befus A.D. Review: mucosal immunology. Immunol 1980; 41: 249
- Genco R.J., Linzer R., Evans R.T. Effect of adjuvants on orally administered antigens. Annals N. Y. Acad. Sci 1983; 409: 650
- McNabb P.C., Tomasi T.B. Host defence mechanisms at mucosal surfaces. Ann. Rev. Microbiol 1981; 35: 477
- Tomasi T.B., Tan E.M., Solomon A., Prendergast R.A. Characteristics of an immune system common to certain external secretions. J. Exp. Med 1965; 121: 101
- Rosenthal M. Effect of a bacterial extract on cellular and humoral responses in humans. J. Immunopharmacol 1986; 8: 315
- Finland M., Jones W. F., Jr., Barnes M.W. Occurrence of serious bacterial infections since the introduction of antibacterial agents. J. Am. Med. Assoc 1959; 170: 2188
- Schimpf S.C., Greene W.H., Young V.M., Wiernick P.H. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J. Infect. Dis 1974; 130: S24
- Pennington J.E., Reynolds H.Y., Carbone P.P. Pseudomonas pneumoniae. A retrospective study of 36 cases. Am. J. Med 1973; 55: 155
- Schook L.B., Carrick L., Jr., Berk R.S. Experimental pulmonary infection of mice by tracheal intubation of Pseudomonas aeruginosa: the use of antineoplasic agents to overcome natural resistance. Can. J. Microbiol 1977; 23: 823
- Boring W.D., Zu Rhein G.M., Walker D.L. Factors influencing host-virus interactions. II. Alteration of Coxsackie virus infection in adult mice by cold. Proc. Soc. Exp. Biol. Med 1956; 93: 273
- Davies M. Phase variations in the modulation of the immune response. Immunology Today 1983; 4: 103